Tools of Trade: Impact of HD Technology on Patient Outcomes


2:00     Monitoring Lung Congestion: What Can We Learn from the CHF Model? – TBD

2:30     Clinical Significance of Achievable Reductions in B2 M levels – Are We Making a Difference? – Bernard Canaud, MD, PhD

3:00     Expanded Hemodialysis and Clinical Outcomes –TBD

3:30     An Update on iHemo – TBD

4:00     Adjourn